在癌症治疗纳米药物策略的最新进展
Qandeel Khalid1, Mubashar Rehman1, Yi-Feng Wang1
1School of Biomedical Engineering & the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510260, Guangdong, PR China.
Biochemical and biophysical research communications
|July 2, 2025
概括
下一代纳米药物提供精确,适应性癌症治疗. 像纳米疫苗和治疗术等创新是有前途的,但必须克服制造和监管障碍,才能在临床使用.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 癌症纳米医学正在迅速发展,专注于精度.
- 目前的方法利用多功能,适应性和瘤特异性的策略.
研究的目的:
- 审查癌症纳米医学的新兴创新.
- 讨论这些先进的治疗平台的潜力和挑战.
主要方法:
- 关于先进纳米医学策略的当前文献的综述.
- 讨论刺激响应,仿生,纳米酶,纳米疫苗,免疫疗法和治疗神经的平台.
主要成果:
- 新兴的纳米药物能够控制治疗,深入瘤透和免疫重编程,降低毒性.
- 临床前数据对这些新的方法非常有希望.
结论:
- 仍然存在重大挑战,包括可扩展的制造,监管批准和针对患者的优化.
- 人工智能和仿生工程是推动临床翻译和改造精确瘤学的关键.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


